Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.25 USD | +0.65% | +3.10% | +97.37% |
May. 02 | Dyne Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 30 | Morgan Stanley Starts Dyne Therapeutics With Overweight Rating, $40 Price Target | MT |
- Stock Market
- Equities
- DYN Stock
- News Dyne Therapeutics, Inc.
- MarketScreener Strategies